Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placental Transfer of Sugammadex in the Human Placental Perfusion Model
NCT06634355Enrolling by invitation
- Sponsor
- UZ Leuven
- Start
- Mar 2025
- Primary completion
- Sep 2026
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of Sugammadex, sponsored by UZ Leuven. Primary endpoint: Foetal-maternal ratio of the drug at Day 0. Started Mar 2025; status: enrolling by invitation.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on NCT06634355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06634355.